NEW YORK (GenomeWeb) – Biodesy said today it has closed a $10 million Series B financing round led by existing investors 5AM Ventures, Pfizer Venture Investments, and Roche Venture Fund.

The company said that proceeds from the round would be used to expand and accelerate commercialization of its Delta System, a high-throughput platform for measuring protein conformational change.

The company also today announced that the platform is now available worldwide.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.